Retatrutide engages GIP, GLP-1 and glucagon receptors; tirzepatide engages GIP and GLP-1. This side-by-side reference compares receptor pharmacology and in-vitro literature for NZ researchers.
Retatrutide vs tirzepatide is one of the most active comparisons in current incretin-receptor research literature. Both are synthetic peptides with fatty-acid diacid linkers studied for albumin association in stability assays, but retatrutide (LY3437943) adds glucagon-receptor agonism to tirzepatide's dual GIP + GLP-1 profile. This reference compares the two purely at the level of structure and in-vitro receptor pharmacology.
Retatrutide vs tirzepatide: quick reference table
| Attribute | Retatrutide | Tirzepatide |
|---|---|---|
| Receptors studied | GIP + GLP-1 + Glucagon | GIP + GLP-1 |
| Research class | Triple incretin/glucagon agonist | Dual incretin agonist |
| Development code | LY3437943 | LY3298176 |
| Length | 39 residues | 39 residues |
| Average mass | ~4731 Da | ~4813.5 Da |
| Albumin-binding strategy | Fatty-acid diacid linker | C20 diacid at Lys20 |
Receptor pharmacology gap: what the glucagon receptor adds
Tirzepatide already covers two of the three incretin/glucagon receptor systems studied in this literature. Retatrutide adds glucagon receptor (GCG-R) agonism, which is characterised in hepatocyte and reporter-assay systems as a distinct signalling pathway from GIP or GLP-1 receptor activation.
- GIP receptor (both peptides): studied in adipocyte and cAMP-reporter assay systems.
- GLP-1 receptor (both peptides): studied via cAMP accumulation in GLP-1R-transfected cell lines.
- Glucagon receptor (retatrutide only): studied in hepatocyte and GCG-R reporter models.
- Balanced in-vitro potency across all three receptors is what distinguishes retatrutide from earlier multi-receptor candidates in the published screening literature.
In-vitro assay comparison
| Assay focus | Retatrutide | Tirzepatide |
|---|---|---|
| Receptor panel studied | GIP-R, GLP-1R, GCG-R | GIP-R, GLP-1R |
| Reporter assay type | Parallel cAMP reporter panel | Parallel cAMP reporter panel |
| Plasma stability studies | Serum incubation + LC-MS | Serum incubation + LC-MS |
| Selectivity screening | Comparative multi-receptor panel | Comparative dual-receptor panel |
Structural comparison
Both peptides share a GIP-derived backbone with substitutions engineered to confer cross-receptor activity, plus a fatty-acid diacid linker studied for its role in reversible albumin association during serum-stability assays. The additional glucagon-receptor cross-reactivity in retatrutide is attributed to specific residue substitutions distinct from those conferring GLP-1 cross-activity in tirzepatide.
Analytical documentation expectations
- Batch identifier and synthesis date traceable to the lot record
- HPLC purity ≥98% (typically ≥99% for peptides under 30 residues)
- LC-MS confirmed monoisotopic or average mass within ±0.5 Da of theoretical
- Counterion identity and content (acetate or trifluoroacetate) reported
- Bacterial endotoxin and residual solvents per the analytical method
Sourcing research-grade retatrutide and tirzepatide in New Zealand
Kiwi Peps supplies both retatrutide and tirzepatide verified to the KP-99 Purity Standard (99%+ HPLC-MS), with batch data available in The Batch Book and Bench-Ready Dispatch nationwide. Strictly for in-vitro research use only.
Frequently asked questions
What is the mechanistic difference between retatrutide and tirzepatide?
Retatrutide is studied as a triple agonist of GIP, GLP-1 and glucagon receptors. Tirzepatide is studied as a dual agonist of only GIP and GLP-1 receptors.
How do the molecular weights compare?
Retatrutide has an average mass of approximately 4731 Da; tirzepatide is approximately 4813.5 Da. Both are 39-residue peptides.
Are retatrutide and tirzepatide interchangeable in research protocols?
No. They engage different receptor panels, so assay protocols and reporter systems should be selected to match the receptor(s) under study.
How does Kiwi Peps verify purity for both peptides?
Every batch is tested to the KP-99 Purity Standard (99%+ HPLC-MS) and logged in The Batch Book with a downloadable certificate of analysis.
